Skip to main content
INCY
NASDAQ Life Sciences

Incyte Swings to $3.60/Share Loss but Beats on Revenue, Tops Lowered Bar

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$115.2
Mkt Cap
$23.351B
52W Low
$88.2
52W High
$132.6
52W Position info
31% above low
Off High info
13% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

INCY sits 31% above its 52-week low of $88.2.

Summary

Incyte posted a Q3 adjusted loss of $3.60 a share, better than the $3.85 loss analysts expected, on revenue of $1.56 billion that rose 14% and beat the $1.47 billion consensus. The GAAP picture is ugly: a $784.8 million quarterly loss, or $3.86 a share, versus $2.26 of EPS a year ago. The beat is against a bar that was cut hard — the mean estimate fell about 38.2% over three months and eight analysts revised lower in the last 30 days — so the quality of the surprise is thin. This lands alongside this morning's raise of full-year 2026 net sales guidance to $5.21-$5.30 billion from $5.13-$5.26 billion, which is the more important number for the thesis. Shares are down 3.7% this quarter but up 18.3% year to date, and the median price target of $130 sits about 10.1% above the last close of $116.87.

At the time of this announcement, INCY was trading at $115.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.4B. The 52-week trading range was $88.20 to $132.60. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INCY - Latest Insights

INCY
Oct 29, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $116.80
Real-time Price: $120.02 info
Change: +$3.22 (+3%) info
Market Cap: $24.658B info
INCY
Oct 29, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $117.76
Real-time Price: $120.02 info
Change: +$2.26 (+2%) info
Market Cap: $24.658B info
INCY
Aug 31, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $123.22
Real-time Price: $120.02 info
Change: -$3.20 (-3%) info
Market Cap: $24.658B info
INCY
Jul 29, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $119.00
Real-time Price: $120.02 info
Change: +$1.02 (+0.86%) info
Market Cap: $24.658B info
INCY
Jul 29, 2026, 4:36 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $119.00
Real-time Price: $120.02 info
Change: +$1.02 (+0.86%) info
Market Cap: $24.658B info